Proceeds will help enhance workflows and expand single-cell functional assay portfolio * Brad Crutchfield joins as advisor to support early access ...
Novigenix AI, a leader in AI-driven healthcare solutions, today announced the presentation of new data at the American Association for Cancer Research (AACR) 2026 Annual Meeting demonstrating, for the ...
Cambridge-based life sciences specialist Lightcast has raised $27 million from global backers to swell its total funding to ...
Lightcast, a pioneering life science tools company focused on functional single-cell analysis, today announced the closing of a $27 million financing raised from existing investors. The financing was ...
Leveraging an AI-powered omnimodal foundation model to accelerate drug discovery, optimize patient stratification, and de-risk clinical developmentWALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a ...
Tempus AI TEM shares are up on Tuesday as the company announced the acceptance of 31 abstracts for presentation at the ...
Qlucore, listed on Nasdaq First North, announces the launch of a new Qlucore Insights test (Research Use Only) specifically developed for Acute Myeloid Leukemia (AML). The software-based test delivers ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the acceptance of 31 abstracts-including one oral presentation-for the ...
Leveraging AI-Driven Multiomics and Spatial Biology to Unlock the Full Potential of Next-Generation Cytotoxic Dual Checkpoint InhibitorWALTHAM, Mass. & HOUSTON--(BUSINESS WIRE)--BostonGene, developer ...
Trials of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, are documenting its direct kidney effects and broad benefits for diabetic kidney disease.
Helical has raised $10M to build the application layer that makes bio foundation models reproducible in pharma R&D. It’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results